See more : Sylvania Platinum Limited (SLP.L) Income Statement Analysis – Financial Results
Complete financial analysis of Molecule Holdings Inc. (MLCL.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Molecule Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Dyadic International, Inc. (DYAI) Income Statement Analysis – Financial Results
- China Oceanwide Holdings Limited (0715.HK) Income Statement Analysis – Financial Results
- Lingsen Precision Industries, Ltd. (2369.TW) Income Statement Analysis – Financial Results
- PRT Company Limited (PRT.AX) Income Statement Analysis – Financial Results
- TAV Havalimanlari Holding A.S. (TAVHY) Income Statement Analysis – Financial Results
Molecule Holdings Inc. (MLCL.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.molecule.ca
About Molecule Holdings Inc.
Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It offers its beverage products under the PHRESH, embody, and CANAJO brands. The company is based in Lansdowne, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 1.97M | 455.26K | 0.00 | 0.00 |
| Cost of Revenue | 3.04M | 955.00K | 47.98K | 27.99K |
| Gross Profit | -1.07M | -499.74K | -47.98K | -27.99K |
| Gross Profit Ratio | -54.56% | -109.77% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.59M | 2.69M | 1.88M | 1.07M |
| Selling & Marketing | 927.95 | 27.90K | 14.19K | 0.00 |
| SG&A | 2.66M | 2.69M | 1.88M | 1.07M |
| Other Expenses | 0.00 | 202.00K | -48.96K | 27.99K |
| Operating Expenses | 2.80M | 2.89M | 1.83M | 1.10M |
| Cost & Expenses | 5.88M | 3.85M | 1.83M | 1.10M |
| Interest Income | 3.14K | 365.00 | 7.73K | 21.38K |
| Interest Expense | 634.93K | 660.60K | 44.59K | 15.51K |
| Depreciation & Amortization | 39.77K | 567.06K | 47.98K | 27.99K |
| EBITDA | -3.87M | -3.36M | -3.23M | -1.05M |
| EBITDA Ratio | -196.57% | -620.09% | 0.00% | 0.00% |
| Operating Income | -3.91M | -3.39M | -3.22M | -1.08M |
| Operating Income Ratio | -198.86% | -744.65% | 0.00% | 0.00% |
| Total Other Income/Expenses | -629.56K | -837.27K | -1.40M | 5.86K |
| Income Before Tax | -4.54M | -4.23M | -3.33M | -1.09M |
| Income Before Tax Ratio | -230.84% | -928.56% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 664.01K | -1.35M | 15.51K |
| Net Income | -4.54M | -4.89M | -1.98M | -1.11M |
| Net Income Ratio | -230.84% | -1,074.42% | 0.00% | 0.00% |
| EPS | -0.05 | -0.05 | -0.03 | -0.24 |
| EPS Diluted | -0.05 | -0.05 | -0.03 | -0.24 |
| Weighted Avg Shares Out | 97.11M | 91.86M | 75.71M | 4.66M |
| Weighted Avg Shares Out (Dil) | 97.11M | 91.86M | 75.71M | 4.66M |
Source: https://incomestatements.info
Category: Stock Reports